World Journal of Clinical Oncology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 7

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

137

HTML

2047

Figures (1-3)

410

Tables (1-3)

440

Sum=3034

Publishing Process of This Article

Item

Count

Browse

106

Download

646

Sum=752

Jul 24, 2024 (publication date) through Feb 13, 2026

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Syed N, Chintakuntlawar AV, Vilasini D, Al Salami AM, Al Hasan R, Afrooz I, Uttam Chandani K, Chandani AU, Chehal A. Low testing rates and high BRCA prevalence: Poly (ADP-ribose) polymerase inhibitor use in Middle East BRCA/homologous recombination deficiency-positive cancer patients. World J Clin Oncol 2024; 15(7): 848-858 [PMID: 39071455 DOI: 10.5306/wjco.v15.i7.848]
URL:	https://www.wjgnet.com/2218-4333/full/v15/i7/848.htm

Number	Citing Articles
1	Emad Shash, Mehemet Ali Vardar, Cagatay Taskiran, Salha Boujassoum, Jamila Riromar, Ahmed Aboutaleb, Farah Sadek, Eman Samy, Waleed Bahaj. Homologous recombination deficiency in newly diagnosed advanced ovarian cancer across nine Middle East countries: prevalence, real-world testing pathways, and treatment implications. BMC Cancer 2026; doi: 10.1186/s12885-025-15537-3